HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A subepidermal blistering disease with histopathological features of dermatitis herpetiformis and immunofluorescence characteristics of bullous pemphigoid: a novel subepidermal blistering disease or a variant of bullous pemphigoid?

Abstract
A 64-year-old man presented with a bullous eruption which clinically and histopathologically resembled dermatitis herpetiformis. However, direct immunofluorescence analysis showed IgG deposits at the basement membrane zone, indicating a relationship with bullous pemphigoid or epidermolysis bullosa acquisita. Indirect immunofluorescence studies on salt-split skin showed binding of IgG mainly on the dermal side of the blister. Immunoblot analysis revealed a novel 200 kDa dermal antigen that could be associated with a major pathogen in this blistering disease. The histopathological similarity to dermatitis herpetiformis and the immunofluorescence findings indicating bullous pemphigoid or epidermolysis bullosa acquisita seem typical of a distinct subepidermal blistering disease characterized by this 200 kDa antigen. However, the pathogenetic role of autoantibodies against this antigen should be further elucidated before confirming whether this case represents a novel subepidermal blistering disease or a special variant of bullous pemphigoid.
AuthorsW Salmhofer, Y Kawahara, H P Soyer, H Kerl, T Nishikawa, T Hashimoto
JournalThe British journal of dermatology (Br J Dermatol) Vol. 137 Issue 4 Pg. 599-604 (Oct 1997) ISSN: 0007-0963 [Print] England
PMID9390339 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantigens
  • Immunoglobulin G
Topics
  • Autoantigens (analysis)
  • Basement Membrane (immunology)
  • Dermatitis Herpetiformis (pathology)
  • Diagnosis, Differential
  • Fluorescent Antibody Technique
  • Humans
  • Immunoglobulin G (analysis)
  • Male
  • Middle Aged
  • Pemphigoid, Bullous (classification, immunology)
  • Skin Diseases, Vesiculobullous (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: